Anixa Biosciences Secures Korean Patent for Innovative Breast Cancer Vaccine Technology Anixa Biosciences has received a crucial patent from Korea's MOIP for its breast cancer vaccine technology, reinforcing its global position.

Anixa Biosciences Secures Korean Patent for Innovative Breast Cancer Vaccine Technology #South_Korea #Anixa_Biosciences #San_Jose #Breast_Cancer_Vaccine #Korea_Patent

Anixa Biosciences Secures Patent for Innovative Breast Cancer Vaccine Technology in Mexico Anixa Biosciences has received a patent notice from Mexico, enhancing global intellectual property for its breast cancer vaccine technology.

Anixa Biosciences Secures Patent for Innovative Breast Cancer Vaccine Technology in Mexico #United_States #Anixa_Biosciences #San_Jose #Immunotherapy #Breast_Cancer_Vaccine

Anixa Biosciences Takes Charge of Breast Cancer Vaccine Development from Cleveland Clinic Anixa Biosciences has officially transferred the IND for its breast cancer vaccine from Cleveland Clinic, signaling a major step forward in cancer treatment.

Anixa Biosciences Takes Charge of Breast Cancer Vaccine Development from Cleveland Clinic #United_States #Anixa_Biosciences #San_Jose #Cleveland_Clinic #Breast_Cancer_Vaccine

Anixa Biosciences Reveals Promising Phase 1 Results for New Breast Cancer Vaccine The latest findings from Anixa Biosciences highlight significant progress in the development of a breast cancer vaccine with favorable immune responses.

Anixa Biosciences Reveals Promising Phase 1 Results for New Breast Cancer Vaccine #USA #Anixa_Biosciences #San_Jose #Clinical_Trial #Breast_Cancer_Vaccine

Anixa Biosciences Expands Patent Protection for Breast Cancer Vaccine in China Anixa Biosciences has announced the issuance of a Chinese patent for its breast cancer vaccine technology, extending protection into 2040.

Anixa Biosciences Expands Patent Protection for Breast Cancer Vaccine in China #United_States #Anixa_Biosciences #San_Jose #Patent #Breast_Cancer_Vaccine

Precision Tune Auto Care Joins Efforts in Breast Cancer Vaccine Fundraising Initiative In October 2025, Precision Tune Auto Care will participate in a unique fundraiser aimed at supporting breast cancer vaccine research through auto repair services.

Precision Tune Auto Care Joins Efforts in Breast Cancer Vaccine Fundraising Initiative #United_States #Breast_Cancer_Vaccine #Hixson #Brakes_for_Breasts #Precision_Tune

Anixa Biosciences Completes Major Milestone in Breast Cancer Vaccine Clinical Trial Anixa Biosciences has announced the completion of final patient visits in its breast cancer vaccine clinical trial, marking a significant progress toward new cancer therapies.

Anixa Biosciences Completes Major Milestone in Breast Cancer Vaccine Clinical Trial #United_States #Anixa_Biosciences #San_Jose #Cleveland_Clinic #Breast_Cancer_Vaccine

Breast Cancer Vaccine's Breakthrough: New Funding Accelerates Hope for Patients A recent grant of $500,000 aims to advance a promising breast cancer vaccine trial. Discover how this development could transform treatment options for patients.

Breast Cancer Vaccine's Breakthrough: New Funding Accelerates Hope for Patients #USA #Seattle #Cancer_Vaccine_Coalition #Breast_Cancer_Vaccine #UW_Medicine

Anixa Biosciences Advances Breast Cancer Vaccine with Patent Approval in China Anixa Biosciences, Inc. gains significant traction with a newly approved patent for its breast cancer vaccine technology in China, expanding its efforts in global health.

Anixa Biosciences Advances Breast Cancer Vaccine with Patent Approval in China #United_States #Anixa_Biosciences #San_Jose #Immunotherapy #Breast_Cancer_Vaccine

Anixa Biosciences Takes Major Step in Breast Cancer Vaccine Development with FDA IND Transfer Anixa Biosciences is advancing its breast cancer vaccine trials by transferring its FDA IND application. This marks a key milestone following promising Phase 1 results.

Anixa Biosciences Takes Major Step in Breast Cancer Vaccine Development with FDA IND Transfer #United_States #Anixa_Biosciences #San_Jose #Breast_Cancer_Vaccine #FDA_IND_transfer

Anixa Biosciences Secures Canadian Patent for Innovative Breast Cancer Vaccine Technology Anixa Biosciences has received a Notice of Allowance from the Canadian Intellectual Property Office for its breast cancer vaccine technology, expanding its global IP strategy.

Anixa Biosciences Secures Canadian Patent for Innovative Breast Cancer Vaccine Technology #Canada #Anixa_Biosciences #San_Jose #Cleveland_Clinic #Breast_Cancer_Vaccine

Anixa Biosciences Secures U.S. Patent to Enhance Breast Cancer Vaccine Development into the 2040s Anixa Biosciences has been awarded a new patent, extending protection for its breast cancer vaccine technology. This aims to revolutionize preventive oncology with unmatched potential.

Anixa Biosciences Secures U.S. Patent to Enhance Breast Cancer Vaccine Development into the 2040s #USA #Anixa_Biosciences #San_Jose #oncology #Breast_Cancer_Vaccine

Anixa Biosciences' Breast Cancer Vaccine Gains National Attention Through NewsNation Appearance Anixa Biosciences' innovative breast cancer vaccine showcases potential in revolutionizing treatment. CEO Dr. Amit Kumar discusses its exciting prospects on NewsNation.

Anixa Biosciences' Breast Cancer Vaccine Gains National Attention Through NewsNation Appearance #United_States #Anixa_Biosciences #San_Jose #Breast_Cancer_Vaccine #Dr._Amit_Kumar

Anixa Biosciences Concludes Enrollment for Groundbreaking Breast Cancer Vaccine Trial Anixa Biosciences has announced the successful enrollment of participants in its Phase 1 clinical trial for a revolutionary breast cancer vaccine, aiming to prevent cancer recurrence.

Anixa Biosciences Concludes Enrollment for Groundbreaking Breast Cancer Vaccine Trial #United_States #Anixa_Biosciences #San_Jose #Clinical_Trials #Breast_Cancer_Vaccine

Anixa Biosciences Outlines Significant Progress and Key Milestones in Shareholder Letter Anixa Biosciences, under CEO Dr. Amit Kumar, shares substantial progress in cancer treatments and plans for 2025 in a recent letter to shareholders.

Anixa Biosciences Outlines Significant Progress and Key Milestones in Shareholder Letter #United_States #Anixa_Biosciences #San_Jose #CAR-T_therapy #Breast_Cancer_Vaccine

Anixa Biosciences' Innovative Approaches to Cancer Treatment Explored by CEO in Exclusive Interview In a recent interview, Anixa Biosciences' CEO discussed groundbreaking therapies, including CAR-T cell innovations and a breast cancer vaccine, highlighting the future of oncology.

Anixa Biosciences' Innovative Approaches to Cancer Treatment Explored by CEO in Exclusive Interview #USA #Anixa_Biosciences #San_Jose #CAR-T_therapy #Breast_Cancer_Vaccine